Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Douglas A. McIntyre | Mar 29, 2007 at 3:17 PM EDT

Dendreon’s Big Day

This was Dendreon’s (DNDN-NASDAQ) big day, and may be what will end up as the largest battleground stock so far…

Douglas A. McIntyre | Mar 29, 2007 at 2:05 PM EDT

Something More To Targeted Genetics? (TGEN)

Targeted Genetics (TGEN) is doing something unbelievable today. The company posted actual earning this morning when it was supposed to…

Douglas A. McIntyre | Mar 29, 2007 at 3:36 AM EDT

Wednesday’s Top Biotech & Medical Stocks

Biotechnology DENDREON CORP [DNDN] +12.99% DIVERSA CORP [DVSA] +11.11% CYTOKINETICS [CYTK] +10.57% BIOSANTE PHARMA INC [BPA] +8.48% CYTORI THERAPEUTICS [CYTX]…

Douglas A. McIntyre | Mar 28, 2007 at 3:01 AM EDT

Tuesday’s Top Biotech & Medical Stocks

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotechnology NUVELO INC NEW [NUVO] +24.92% NEOSE TECH INC [NTEC] +20.67% CARDIOVASCULAR BIOTH…

Douglas A. McIntyre | Mar 28, 2007 at 2:58 AM EDT

eXegenics: Dr.Frost Continues His Hot Hand

by H.S. AyoubBioHealth Investor.com Back in February, I recommended investing in Continucare (CNU) after doctor Phillip Frost, founder of Ivax…

Douglas A. McIntyre | Mar 28, 2007 at 1:29 AM EDT

Dendreon’s Last Day (Ahead of the FDA)

Dendreon (DNDN-NASDAQ) has only 1 trading day left before its FDA panel meeting over the potential backing of its Provenge…

Douglas A. McIntyre | Mar 27, 2007 at 3:10 AM EDT

Patient Investors: Take a Look at Amgen

From Chad Brand at Peridot Capitalist As a value investor, it is often easier to find undiscovered or unloved stocks…

Douglas A. McIntyre | Mar 27, 2007 at 3:08 AM EDT

Weekly Top Biotech and Medical Business Articles

From BioHealth Investor by H.S. AyoubBioHealth Investor.com The following articles were the most popular at BioHealth Investor for the week…

Douglas A. McIntyre | Mar 26, 2007 at 6:04 PM EDT

CombinatoRx, Maybe Not As Bad As It Looked

CombinatoRx (CRXX) is still down in after-hours trading, but nowhere near the levels that it looked like the stock was…

Douglas A. McIntyre | Mar 26, 2007 at 3:30 PM EDT

Biotech Implosion: CombinatoRx (CRXX)

If having a difficult to say and spell name wasn’t bad enough, issuing poor study results will do it. CombinatoRx,…

Douglas A. McIntyre | Mar 26, 2007 at 2:09 PM EDT

Two Less Followed Stent-Related Companies At Risk

There are two companies that are not as frequently referred to in stent-land, and depending on how you interpret today’s…

Douglas A. McIntyre | Mar 26, 2007 at 8:26 AM EDT

Boston Scientific Bad Hair Day: Stent Applications Narrow

A new, very large test, shows that bare-metal stents barely work in patients with chronic chest pain who have their…

Douglas A. McIntyre | Mar 26, 2007 at 8:18 AM EDT

Pfizer Gets Bitten

Life does not get any easier for Pfizer (PFE). Forget generics. Now other drug firms are ganging up on them.…

Douglas A. McIntyre | Mar 26, 2007 at 4:00 AM EDT

A Make or Break Week for Dendreon (DNDN)

Dendreon(DNDN-NASDAQ) is going to be one of "THE TOP ISSUES" this week. The company will have and FDA review panel…

Douglas A. McIntyre | Mar 26, 2007 at 3:23 AM EDT

IBD Weekly Top Ranked Medical Stocks

The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s…

1 … 375 376 377 378 379 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Dendreon’s Big Day

Something More To Targeted Genetics? (TGEN)

Wednesday’s Top Biotech & Medical Stocks

Tuesday’s Top Biotech & Medical Stocks

eXegenics: Dr.Frost Continues His Hot Hand

Dendreon’s Last Day (Ahead of the FDA)

Patient Investors: Take a Look at Amgen

Weekly Top Biotech and Medical Business Articles

CombinatoRx, Maybe Not As Bad As It Looked

Biotech Implosion: CombinatoRx (CRXX)

Two Less Followed Stent-Related Companies At Risk

Boston Scientific Bad Hair Day: Stent Applications Narrow

Pfizer Gets Bitten

A Make or Break Week for Dendreon (DNDN)

IBD Weekly Top Ranked Medical Stocks

Dave Ramsey to a Single Mom Facing $14,000 a Year at a $93,000 College: Where You Go to School Does Not Matter

The 4% Rule vs. a Dividend Paycheck: Which Makes $1.25 Million Last Longer?

Why Your Ex-Spouse Could Inherit Your $600,000 401(k) Even After Remarriage

Dave Ramsey to a Single Mom Facing $14,000 a Year at a $93,000 College: Where You Go to School Does Not Matter

The 4% Rule vs. a Dividend Paycheck: Which Makes $1.25 Million Last Longer?

Dave Ramsey to a Single Mom Facing $14,000 a Year at a $93,000 College: Where You Go to School Does Not Matter

The 4% Rule vs. a Dividend Paycheck: Which Makes $1.25 Million Last Longer?

Health and Healthcare Articles

All Health and Healthcare Articles

Dendreon’s Big Day

Something More To Targeted Genetics? (TGEN)

Wednesday’s Top Biotech & Medical Stocks

Tuesday’s Top Biotech & Medical Stocks

eXegenics: Dr.Frost Continues His Hot Hand

Dendreon’s Last Day (Ahead of the FDA)

Patient Investors: Take a Look at Amgen

Weekly Top Biotech and Medical Business Articles

CombinatoRx, Maybe Not As Bad As It Looked

Biotech Implosion: CombinatoRx (CRXX)

Two Less Followed Stent-Related Companies At Risk

Boston Scientific Bad Hair Day: Stent Applications Narrow

Pfizer Gets Bitten

A Make or Break Week for Dendreon (DNDN)

IBD Weekly Top Ranked Medical Stocks

Dave Ramsey to a Single Mom Facing $14,000 a Year at a $93,000 College: Where You Go to School Does Not Matter

The 4% Rule vs. a Dividend Paycheck: Which Makes $1.25 Million Last Longer?

Why Your Ex-Spouse Could Inherit Your $600,000 401(k) Even After Remarriage

Featured Reads

Dave Ramsey to a Single Mom Facing $14,000 a Year at a $93,000 College: Where You Go to School Does Not Matter

The 4% Rule vs. a Dividend Paycheck: Which Makes $1.25 Million Last Longer?